Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity.

In obese mice, diabetes worsened clinical and pathologic outcomes of colitis mechanisms that are reversible with treatment of hyperglycemia. Hyperglycemia-induced intestinal barrier dysfunction offers a plausible mechanism linking diabetes to increased colitis severity. These findings suggest that effective diabetes management may decrease the clinical severity of IBD.